Table 4.
Mucosal And Plaque Score (MPS) from Baseline (B) Among the Intervention (I) and Control (C) Group to Three- And Six-Month Follow-Ups
| MPS | B–3 Months | B–6 Months | 3–6 Months | |||
|---|---|---|---|---|---|---|
| p-value | 0.77 | 0.42 | 0.51 | |||
| I (n=70) | C (n=61) | I (n=69) | C (n=55) | I (n=69) | C (n=55) | |
| Deteriorated n (%) | 10 (14.29) | 6 (9.84) | 7 (10.14) | 3 (5.45) | 24 (34.78) | 14 (25.45) |
| Unchanged n (%) | 13 (18.57) | 13 (21.31) | 24 (34.78) | 16 (29.09) | 30 (43.48) | 29 (52.73) |
| Improved n (%) | 47 (67.14) | 42 (68.85) | 38 (55.07) | 36 (65.45) | 15 (21.74) | 12 (21.82) |
Abbreviations: n, number of participants.